Codexis outlines $72M–$76M 2026 revenue target as ECO Synthesis gains momentum and CDMO partnerships expand (NASDAQ:CDXS)

Earnings Call InsightsCodexis outlines $72M–$76M 2026 revenue target as ECO Synthesis gains momentum and CDMO partnerships expandMar. 11, 2026 7:52 PM ETCodexis, Inc. (CDXS) StockAI-Generated Earnings Calls InsightsCommentsEarnings Call Insights: Codexis (CDXS) Q4 2025 Management View CEO Alison Moore stated that Codexis is now focused on RNA medicine and has developed the ECO Synthesis manufacturing platform to address challenges in current siRNA production technology. Moore highlighted, "We reached anNews ...